Grant

Combined cancer therapy

Patent Number ES-2965009-T3

Publication Year 2024

Granted Year: 2024

Application Year 2017

Priority Year 2016

Jurisdiction ES

Status Active

Inventors

ANDERSEN MADS

Applicants

  1. IO Biotech ApS
  2. [NORA names: Other Companies; Private Research]

Abstract

The present invention relates to a method for the prevention or treatment of cancer in a subject. The method comprises administering to said subject an immunotherapeutic composition comprising an immune system checkpoint component, or an immunogenic fragment of said component; and an immunomodulatory agent that blocks or inhibits a checkpoint of the immune system, which checkpoint may be the same as or different from the checkpoint of which the composition comprises a component. The invention also relates to said immunotherapeutic composition and said agent, and to kits comprising them. (Automatic translation with Google Translate, without legal value)

Patent Family Records (19)

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS ANDERSEN MADS HALD

2024, SI-3423087-T1

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS ANDERSEN MADS HALD

2024, PL-3423087-T3

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS ANDERSEN MADS

2024, LT-3423087-T

Combination therapy for cancer  

IO Biotech ApS アンデルセン,マッズ,ハルド

2024, JP-7417645-B2

Combination Therapy for Cancer  

IO Biotech ApS アンデルセン,マッズ,ハルド

2024, JP-2024045180-A

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS ANDERSEN MADS

2024, HU-E064857-T2

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS ANDERSEN MADS HALD

2024, HR-P20240052-T1

Combined cancer therapy

IO Biotech ApS ANDERSEN MADS

2024, ES-2965009-T3

COMBINATION THERAPY AGAINST CANCER  

IO Biotech ApS ANDERSEN MADS HALD

2024, EP-4316517-A3

COMBINATION THERAPY AGAINST CANCER  

IO Biotech ApS ANDERSEN MADS HALD

2024, EP-4316517-A2

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS

2023, PT-3423087-T

COMBINATION THERAPY AGAINST CANCER  

IO Biotech ApS ANDERSEN MADS HALD

2023, EP-3423087-B1

Combination therapy against cancer  

IO BIOTECH APS ANDERSEN MADS HALD

2023, DK-3423087-T3

COMBINATION THERAPY FOR CANCER  

IO Biotech ApS ANDERSEN MADS HALD

2022, US-20220257741-A1

Combination therapy for cancer  

IO Biotech ApS MADS HALD ANDERSEN

2022, JP-2022068348-A

COMBINATION THERAPY AGAINST CANCER  

IO Biotech ApS ANDERSEN MADS HALD

2019, US-20190343940-A1

Combination therapy for cancer  

IO Biotech ApS アンデルセン,マッズ,ハルド

2019, JP-2019507180-A

COMBINATION THERAPY AGAINST CANCER  

IO Biotech ApS ANDERSEN MADS HALD

2019, EP-3423087-A1

COMBINATION THERAPY AGAINST CANCER  

IO BIOTECH APS ANDERSEN MADS HALD

2017, WO-2017149150-A1

Data Provider: Digital Science